Conference Proceedings

SRA737, a novel Chk1 inhibitor, shows efficacy in CCNE1-amplified and MYCN-overexpressing high-grade serous ovarian cancer patient-derived xenograft models

GY Ho, H Barker, C Vanderberg, O Kondrashova, E Kyran, E Lieschke, O McNally, A Hamilton, V Heong, R Hansen, S Milutinovic, B Strouse, M Hedrick, C Hassig, D Bowtell, W Matthew, C Scott

EUROPEAN JOURNAL OF CANCER | ELSEVIER SCI LTD | Published : 2018